|
1
|
Bantz SK, Zhu Z and Zheng T: The atopic
march: Progression from atopic dermatitis to allergic rhinitis and
asthma. J Clin Cell Immunol. 5(202)2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wollenberg A, Barbarot S, Bieber T,
Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni
G, Lau S, Muraro A, et al: Consensus-based European guidelines for
treatment of atopic eczema (atopic dermatitis) in adults and
children: Part I. J Eur Acad Dermatol Venereol. 32:657–682.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wollenberg A, Oranje A, Deleuran M, Simon
D, Szalai Z, Kunz B, Svensson A, Barbarot S, von Kobyletzki L,
Taieb A, et al: ETFAD/EADV Eczema task force 2015 position paper on
diagnosis and treatment of atopic dermatitis in adult and
paediatric patients. J Eur Acad Dermatol Venereol. 30:729–747.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Eichenfield LF, Tom WL, Chamlin SL,
Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen
DE, Cooper KD, et al: Guidelines of care for the management of
atopic dermatitis: Section 1 Diagnosis and assessment of atopic
dermatitis. J Am Acad Dermatol. 70:338–351. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Schneider L, Tilles S, Lio P, Boguniewicz
M, Beck L, LeBovidge J, Novak N, Bernstein D, Blessing-Moore J,
Khan D, et al: Atopic dermatitis: A practice parameter update 2012.
J Allergy Clin Immunol. 131:295–299.e1-e27. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bumbacea R, Berghea E and Giurcaneanu C:
Frequency of contact sensitisation in children with atopic
dermatitis. Allergy. 62 (Suppl 83):S319. 2007.
|
|
7
|
Werfel T, Allam JP, Biedermann T, Eyerich
K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU,
Wollenberg A, et al: Cellular and molecular immunologic mechanisms
in patients with atopic dermatitis. J Allergy Clin Immunol.
138:336–349. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tokura Y: Extrinsic and intrinsic types of
atopic dermatitis. J Dermatol Sci. 58:1–7. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Valenta R, Mittermann I, Werfel T, Garn H
and Renz H: Linking allergy to autoimmune disease. Trends Immunol.
30:109–116. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Reginald K, Westritschnig K, Linhart B,
Focke-Tejkl M, Jahn-Schmid B, Eckl-Dorna J, Heratizadeh A,
Stöcklinger A, Balic N, Spitzauer S, et al: Staphylococcus
aureus fibronectin-binding protein specifically binds IgE from
patients with atopic dermatitis and requires antigen presentation
for cellular immune responses. J Allergy Clin Immunol.
128:82–91.e8. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hostetler SG, Kaffenberger B, Hostetler T
and Zirwas MJ: The role of airborne proteins in atopic dermatitis.
J Clin Aesthet Dermatol. 3:22–31. 2010.PubMed/NCBI
|
|
12
|
Matricardi PM, Kleine-Tebbe J, Hoffmann
HJ, Valenta R, Hilger C, Hofmaier S, Aalberse RC, Agache I, Asero
R, Ballmer-Weber B, et al: EAACI molecular allergology user's
guide. Pediatr Allergy Immunol. 27 (Suppl 23):S1–S250.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Miller JD: The role of dust mites in
allergy. Clin Rev Allergy Immunol. 57:312–329. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Arlian LG: Water balance and humidity
requirements of house dust mites. Exp Appl Acarol. 16:15–35.
1992.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tovey ER, Chapman MD and Platts-Mills TA:
Mite faeces are a major source of house dust allergens. Nature.
289:592–593. 1981.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Thomas WR: Hierarchy and molecular
properties of house dust mite allergens. Allergol Int. 64:304–311.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vrtala S, Huber H and Thomas WR:
Recombinant house dust mite allergens. Methods. 66:67–74.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nakamura T, Hirasawa Y, Takai T, Mitsuishi
K, Okuda M, Kato T, Okumura K, Ikeda S and Ogawa H: Reduction of
skin barrier function by proteolytic activity of a recombinant
house dust mite major allergen Der f 1. J Invest Dermatol.
126:2719–2723. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Steinhoff M, Neisius U, Ikoma A, Fartasch
M, Heyer G, Skov PS, Luger TA and Schmelz M: Proteinase-activated
receptor-2 mediates itch: A novel pathway for pruritus in human
skin. J Neurosci. 23:6176–6180. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jeong SK, Kim HJ, Youm JK, Ahn SK, Choi
EH, Sohn MH, Kim KE, Hong JH, Shin DM and Lee SH: Mite and
cockroach allergens activate protease-activated receptor 2 and
delay epidermal permeability barrier recovery. J Invest Dermatol.
128:1930–1939. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kato T, Takai T, Fujimura T, Matsuoka H,
Ogawa T, Murayama K, Ishii A, Ikeda S, Okumura K and Ogawa H: Mite
serine protease activates protease-activated receptor-2 and induces
cytokine release in human keratinocytes. Allergy. 64:1366–1374.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Willumsen N, Holm J, Christensen LH,
Würtzen PA and Lund K: The complexity of allergic patients' IgE
repertoire correlates with serum concentration of allergen-specific
IgE. Clin Exp Allergy. 42:1227–1236. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jang YH, Choi JK, Jin M, Choi YA, Ryoo ZY,
Lee HS, Park PH, Kim SU, Kwon TK, Jang MH, et al: House dust mite
increases pro-Th2 cytokines IL-25 and IL-33 via the activation of
TLR1/6 signaling. J Invest Dermatol. 137:2354–2361. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hallai N and Gawkrodger DJ: Patch testing
to aeroallergens, especially house dust mite, is often positive in
atopics with eczema of the face and hands. J Eur Acad Dermatol
Venereol. 23:728–730. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tuft L: Importance of inhalant allergens
in atopic dermatitis. J Invest Dermatol. 12:211–219.
1949.PubMed/NCBI
|
|
26
|
Friedmann PS: Dust mite avoidance in
atopic dermatitis. Clin Exp Dermatol. 24:433–437. 1999.PubMed/NCBI View Article : Google Scholar
|
|
27
|
van Reijsen FC, Bruijnzeel-Koomen CA,
Kalthoff FS, Maggi E, Romagnani S, Westland JK and Mudde GC:
Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype
in patients with atopic dermatitis. J Allergy Clin Immunol.
90:184–193. 1992.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Banerjee S, Resch Y, Chen KW, Swoboda I,
Focke-Tejkl M, Blatt K, Novak N, Wickman M, van Hage M, Ferrara R,
et al: Der p 11 is a major allergen for house dust mite-allergic
patients suffering from atopic dermatitis. J Invest Dermatol.
135:102–109. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Resch Y, Blatt K, Malkus U, Fercher C,
Swoboda I, Focke-Tejkl M, Chen KW, Seiberler S, Mittermann I,
Lupinek C, et al: Molecular, structural and immunological
characterization of Der p 18, a Chitinase-like house dust mite
allergen. PLoS One. 11(e0160641)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Resch Y, Michel S, Kabesch M, Lupinek C,
Valenta R and Vrtala S: Different IgE recognition of mite allergen
components in asthmatic and nonasthmatic children. J Allergy Clin
Immunol. 136:1083–1091. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Becker S, Schlederer T, Kramer MF, Haack
M, Vrtala S, Resch Y, Lupinek C, Valenta R and Gröger M: Real-life
study for the diagnosis of house dust mite allergy - the value of
recombinant allergen-based IgE serology. Int Arch Allergy Immunol.
170:132–137. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mittermann I, Wikberg G, Johansson C,
Lupinek C, Lundeberg L, Crameri R, Valenta R and Scheynius A: IgE
sensitization profiles differ between adult patients with severe
and moderate atopic dermatitis. PLoS One.
11(e0156077)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Gaitanis G, Magiatis P, Hantschke M,
Bassukas ID and Velegraki A: The Malassezia genus in skin and
systemic diseases. Clin Microbiol Rev. 25:106–141. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lagier B, Pons N, Rivier A, Chanal I,
Chanez P, Bousquet J and Pène J: Seasonal variations of
interleukin-4 and interferon-gamma release by peripheral blood
mononuclear cells from atopic subjects stimulated by polyclonal
activators. J Allergy Clin Immunol. 96:932–940. 1995.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bousquet J, Anto JM, Wickman M, Keil T,
Valenta R, Haahtela T, Lodrup Carlsen K, van Hage M, Akdis C,
Bachert C, et al: Are allergic multimorbidities and IgE
polysensitization associated with the persistence or re-occurrence
of foetal type 2 signalling? The MeDALL hypothesis. Allergy.
70:1062–1078. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Campana R, Dzoro S, Mittermann I, Fedenko
E, Elisyutina O, Khaitov M, Karaulov A and Valenta R: Molecular
aspects of allergens in atopic dermatitis. Curr Opin Allergy Clin
Immunol. 17:269–277. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Posa D, Perna S, Resch Y, Lupinek C,
Panetta V, Hofmaier S, Rohrbach A, Hatzler L, Grabenhenrich L,
Tsilochristou O, et al: Evolution and predictive value of IgE
responses toward a comprehensive panel of house dust mite allergens
during the first 2 decades of life. J Allergy Clin Immunol.
139:541–549, e8. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Bremmer SF and Simpson EL: Dust mite
avoidance for the primary prevention of atopic dermatitis: A
systematic review and meta-analysis. Pediatr Allergy Immunol.
26:646–654. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Arlian LG and Platts-Mills TA: The biology
of dust mites and the remediation of mite allergens in allergic
disease. J Allergy Clin Immunol. 107 (Suppl):S406–S413.
2001.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fieten KB, Weststrate AC, van Zuuren EJ,
Bruijnzeel-Koomen CA and Pasmans SG: Alpine climate treatment of
atopic dermatitis: A systematic review. Allergy. 70:12–25.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Emerson RM, Williams HC and Allen BR: What
is the cost of atopic dermatitis in preschool children? Br J
Dermatol. 144:514–522. 2001.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Charman CR, Morris AD and Williams HC:
Topical corticosteroid phobia in patients with atopic eczema. Br J
Dermatol. 142:931–936. 2000.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Bumbăcea RS, Deaconu CG and Berghea EC:
Management problems in severe chronic inducible urticaria: Two case
reports. Exp Ther Med. 18:960–963. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Solomon I, Ilie MA, Draghici C, Voiculescu
VM, Căruntu C, Boda D and Zurac S: The impact of lifestyle factors
on evolution of atopic dermatitis: An alternative approach. Exp
Ther Med. 17:1078–1084. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tan BB, Weald D, Strickland I and
Friedmann PS: Double-blind controlled trial of effect of
housedust-mite allergen avoidance on atopic dermatitis. Lancet.
347:15–18. 1996.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ricci G, Patrizi A, Specchia F, Menna L,
Bottau P, D'Angelo V and Masi M: Effect of house dust mite
avoidance measures in children with atopic dermatitis. Br J
Dermatol. 143:379–384. 2000.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Nankervis H, Pynn EV, Boyle RJ, Rushton L,
Williams HC, Hewson DM and Platts-Mills T: House dust mite
reduction and avoidance measures for treating eczema. Cochrane
Database Syst Rev. 1(CD008426)2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sidbury R, Tom WL, Bergman JN, Cooper KD,
Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis
DM, et al: Guidelines of care for the management of atopic
dermatitis: Section 4 Prevention of disease flares and use of
adjunctive therapies and approaches. J Am Acad Dermatol.
71:1218–1233. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Bussmann C, Böckenhoff A, Henke H, Werfel
T and Novak N: Does allergen-specific immunotherapy represent a
therapeutic option for patients with atopic dermatitis? J Allergy
Clin Immunol. 118:1292–1298. 2006.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Darsow U, Forer I and Ring J:
Allergen-specific immunotherapy in atopic eczema. Curr Allergy
Asthma Rep. 11:277–283. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Werfel T, Breuer K, Ruéff F, Przybilla B,
Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, et al:
Usefulness of specific immunotherapy in patients with atopic
dermatitis and allergic sensitization to house dust mites: A
multi-Centre, randomized, dose-response study. Allergy. 61:202–205.
2006.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Svejgaard E, Larsen PO, Deleuran M,
Ternowitz T, Roed-Petersen J and Nilsson J: Treatment of head and
neck dermatitis comparing itraconazole 200 mg and 400 mg daily for
1 week with placebo. J Eur Acad Dermatol Venereol. 18:445–449.
2004.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Lee J, Park CO and Lee KH: Specific
immunotherapy in atopic dermatitis. Allergy Asthma Immunol Res.
7:221–229. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Pajno GB, Caminiti L, Vita D, Barberio G,
Salzano G, Lombardo F, Canonica GW and Passalacqua G: Sublingual
immunotherapy in mite-sensitized children with atopic dermatitis: A
randomized, double-blind, placebo-controlled study. J Allergy Clin
Immunol. 120:164–170. 2007.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Akdis CA, Barlan IB, Bahceciler N and
Akdis M: Immunological mechanisms of sublingual immunotherapy.
Allergy. 61 (Suppl 81):S11–S14. 2006.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Glover MT and Atherton DJ: A double-blind
controlled trial of hyposensitization to Dermatophagoides
pteronyssinus in children with atopic eczema. Clin Exp Allergy.
22:440–446. 1992.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Pajno GB, Caminiti L, Crisafulli G,
Barberi S, Landi M, Aversa T, Valenzise M and Passalacqua G:
Adherence to sublingual immunotherapy in preschool children.
Pediatr Allergy Immunol. 23:688–689. 2012.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Novak N, Bieber T, Hoffmann M,
Fölster-Holst R, Homey B, Werfel T, Sager A and Zuberbier T:
Efficacy and safety of subcutaneous allergen-specific immunotherapy
with depigmented polymerized mite extract in atopic dermatitis. J
Allergy Clin Immunol. 130:925–931.e4. 2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Bae JM, Choi YY, Park CO, Chung KY and Lee
KH: Efficacy of allergen-specific immunotherapy for atopic
dermatitis: A systematic review and meta-analysis of randomized
controlled trials. J Allergy Clin Immunol. 132:110–117.
2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Wollenberg A, Barbarot S, Bieber T,
Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni
G, Lau S, Muraro A, et al: Consensus-based European guidelines for
treatment of atopic eczema (atopic dermatitis) in adults and
children: Part II. J Eur Acad Dermatol Venereol. 32:850–878.
2018.PubMed/NCBI View Article : Google Scholar
|
